2-Methyltetrahydrofuran (stabilised with BHT), 99.0%, 100ml

1,3,5-Trimethyl-1H-pyrazol-4-ylamine, 97.0%, 25g

SODIUM 2-(ISOQUINOLIN-1-YL)ACETATE, 95%, 100mg

ethyl 1H-1,2,4-triazole-5-carboxylate, 95.0%, 10g

(1-(P-tolyl)-1H-pyrazol-4-yl)boronic acid, 95.0%, 1g

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1), 99%, 25g

3-Amino-2-bromo-4-methylpyridine, 98.0%, 25g

2,7-Dimethoxy-9H-thioxanthen-9-one>95.0%(GC)1g

2-(3-(Hydroxymethyl)oxetan-3-yl)acetonitrile, 95%, 1g

H-D-LEU-OTBU.HCL, 95.0%, 10g

2,2'-(9,9-Diphenyl-9H-fluorene-2,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 97%, 100mg

Acetyl-5-hydroxy-tryptamine, 98.0%, 100mg

Silica gel 1000, 250 g